drugset / Trial / NCT07282769

Semaglutide (Wegovy) Treatment for Trichotillomania

NCT07282769

Phase 2 Not yet recruiting 10 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.

Timeline

Start
2026-06
Primary completion
2027-02
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Semaglutide Peptide

Indications